skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Assignor Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Assignor Name : HE, MINGXUN
Total Assignments: 6
Assignment: 1
Reel/Frame:044410/0010   Pages: 6
Recorded: 12/15/2017
Attorney Dkt #:688452-58US
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
YU, SHANGHAI
Exec Dt:
12/04/2017
2
YANG, FANGLONG
Exec Dt:
12/04/2017
3
CHEN, LEI
Exec Dt:
12/04/2017
4
YAN, JINGJING
Exec Dt:
12/04/2017
5
ZHANG, XIQIAN
Exec Dt:
12/04/2017
6
XIE, ZHICHAO
Exec Dt:
12/04/2017
7
CHEN, LINGXIANG
Exec Dt:
12/04/2017
8
HE, MINGXUN
Exec Dt:
12/04/2017
Assignees
1
JIANGSU HENGRUI MEDICINE CO., LTD.
NO. 7 KUNLUNSHAN ROAD
ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE
LIANYUNGANG, JIANGSU, CHINA 222047
2
SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
NO. 279 WENJING ROAD
MINHANG DISTRICT
SHANGHAI, CHINA 200245
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
10087191
US20180170943
15736898
Correspondence name and address
YOLANDA LOPEZ
PANITCH SCHWARZE BELISARIO & NADEL
ONE COMMERCE SQUARE, 2005 MARKET ST., SUITE 220
PHILADELPHIA, PA 19103-7013
Assignment: 2
Reel/Frame:046139/0718   Pages: 6
Recorded: 06/20/2018
Attorney Dkt #:688452-58U1
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
YU, SHANGHAI
Exec Dt:
12/04/2017
2
YANG, FANGLONG
Exec Dt:
12/04/2017
3
CHEN, LEI
Exec Dt:
12/04/2017
4
YAN, JINGJING
Exec Dt:
12/04/2017
5
ZHANG, XIQIAN
Exec Dt:
12/04/2017
6
XIE, ZHICHAO
Exec Dt:
12/04/2017
7
CHEN, LINGXIANG
Exec Dt:
12/04/2017
8
HE, MINGXUN
Exec Dt:
12/04/2017
Assignees
1
JIANGSU HENGRUI MEDICINE CO., LTD.
NO. 7 KUNLUNSHAN ROAD
ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE
LIANYUNGANG, JIANGSU, CHINA 222047
2
SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
NO. 279 WENJING ROAD
MINHANG DISTRICT
SHANGHAI, CHINA 200245
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
10385060
US20180298020
16012958
Correspondence name and address
JESSICA GODISH
PANITCH SCHWARZE BELISARIO & NADEL LLP
TWO COMMERCE SQUARE 2001 MARKET STREET, SUITE 2800
PHILADELPHIA, PA 19103
Assignment: 3
Reel/Frame:045809/0079   Pages: 5
Recorded: 05/15/2018
Attorney Dkt #:688452-67US
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
LU, BIAO
Exec Dt:
03/04/2018
2
SHEN, XIAODONG
Exec Dt:
03/04/2018
3
HE, MINGXUN
Exec Dt:
03/04/2018
4
LIU, DONG
Exec Dt:
03/04/2018
5
ZHANG, MINSHENG
Exec Dt:
03/04/2018
Assignees
1
JIANGSU HENGRUI MEDICINE CO., LTD.
NO. 7 KUNLUNSHAN ROAD
ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE
LIANYUNGANG, JIANGSU, CHINA 222047
2
SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
NO. 279 WENJING ROAD
MINHANG DISTRICT
SHANGHAI, CHINA 200245
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
10759787
US20180327394
15775958
Correspondence name and address
JESSICA GODISH
PANITCH SCHWARZE BELISARIO & NADEL LLP
TWO COMMERCE SQUARE, 2001 MARKET STREET SUITE 2800
PHILADELPHIA, PA 19103
Assignment: 4
Reel/Frame:053283/0704   Pages: 5
Recorded: 07/22/2020
Attorney Dkt #:065825.11148/57US2
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
LU, BIAO
Exec Dt:
03/04/2018
2
SHEN, XIAODONG
Exec Dt:
03/04/2018
3
HE, MINGXUN
Exec Dt:
03/04/2018
4
LIU, DONG
Exec Dt:
03/04/2018
5
ZHANG, MINSHENG
Exec Dt:
03/04/2018
Assignees
1
JIANGSU HENGRUI MEDICINE CO., LTD.
NO. 7 KUNLUNSHAN ROAD
ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE
LIANYUNGANG, JIANGSU, CHINA 222047
2
SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
NO. 279 WENJING ROAD
MINHANG DISTRICT
SHANGHAI, CHINA 200245
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
11059811
US20200354349
16935407
Correspondence name and address
ICE MILLER LLP
1735 MARKET STREET, SUITE 3450
PHILADELPHIA, PA 19103
Assignment: 5
Reel/Frame:045480/0919   Pages: 6
Recorded: 04/09/2018
Attorney Dkt #:688452-65US
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
LI, XIN
Exec Dt:
03/14/2018
2
FENG, BINQIANG
Exec Dt:
03/14/2018
3
CHEN, YANG
Exec Dt:
03/14/2018
4
LIU, TAO
Exec Dt:
03/14/2018
5
HE, FENG
Exec Dt:
03/15/2018
6
HE, MINGXUN
Exec Dt:
03/14/2018
7
TAO, WEIKANG
Exec Dt:
03/14/2018
8
SUN, PIAOYANG
Exec Dt:
03/21/2018
Assignees
1
JIANGSU HENGRUI MEDICINE CO., LTD.
NO. 7 KUNLUNSHAN ROAD
ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE
LIANYUNGANG, JIANGSU, CHINA 222047
2
SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
NO. 279 WENJING ROAD
MINHANG DISTRICT
SHANGHAI, CHINA 200245
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
10442793
US20180297988
15766985
Correspondence name and address
SHERYL NEUMANN
PANITCH SCHWARZE BELISARIO & NADEL LLP
2001 MARKET STREET, SUITE 2800
PHILADELPHIA, PA 19103-7044
Assignment: 6
Reel/Frame:046065/0585   Pages: 6
Recorded: 06/13/2018
Attorney Dkt #:688452-70US
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
YANG, FANGLONG
Exec Dt:
05/21/2018
2
ZHANG, LING
Exec Dt:
05/21/2018
3
WANG, CHUNFEI
Exec Dt:
05/21/2018
4
HE, MINGXUN
Exec Dt:
05/21/2018
5
HU, QIYUE
Exec Dt:
05/21/2018
6
HE, FENG
Exec Dt:
05/21/2018
7
TAO, WEIKANG
Exec Dt:
05/21/2018
8
SUN, PIAOYANG
Exec Dt:
05/25/2018
Assignees
1
JIANGSU HENGRUI MEDICINE CO., LTD.
NO. 7 KUNLUNSHAN ROAD
ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE
LIANYUNGANG, JIANGSU, CHINA 222047
2
SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
NO. 279 WENJING ROAD
MINHANG DISTRICT
SHANGHAI, CHINA 200245
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
10398689
US20180318284
16061676
Correspondence name and address
SHERYL NEUMANN
PANITCH SCHWARZE BELISARIO & NADEL LLP
2001 MARKET STREET, SUITE 2800
PHILADELPHIA, PA 19103-7044

Search Results as of: 05/01/2024 10:13 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT